Pilot Study Evaluating Biomarker-Guided Nutritional Supplements to Improve Quality of Life in Adults With Chronic Pain

What this Trial Is About

Researchers are evaluating how daily nutritional supplements guided by pain-specific urine biomarkers affect quality of life and urinary biomarker scores in adults with chronic pain lasting at least three months. This study aims to assess whether identifying individual deficiencies and using targeted supplements can help address oxidative stress, inflammation, and nerve health in chronic pain patients. Participants receive one of three dietary supplement formulas based on their specific urinary biomarker test results. The formulas include Inflammation Support, Nerve Health, and Redox Support supplements, each containing various vitamins, minerals, and extracts designed to target different biological pathways related to pain. The supplementation period lasts for three months. During the study, participants urine biomarker levels and quality-of-life measures related to pain are evaluated at one and three months of supplementation and again at a three-month follow-up. Additional assessments include pain intensity, depression and anxiety symptoms, sleep quality, and mood states monitored monthly during supplementation and at follow-up. The total participation spans approximately six months, including treatment and follow-up periods.

Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain